UPDATED: FDA Panel Votes Against COVID Booster Shot For All 16 & Older

September 17, 2021September 17, 2021 editor Coronavirus, COVID-19 vaccine, Pfizer COVID vaccine, U.S. Food and Drug Administration (FDA)

PLEASE SHARE

WASHINGTON DC – A Food & Drug Administration (FDA) panel voted against a proposal by drug-manufacturer Pfizer for booster COVID shots for all Americans age 16 and olde.

The panel votes to approve booster vaccine shots for those age 65 or older and those who are considered high-risk

A CDC advisory panel will meet next week to discuss recommendations for who should receive a booster dose

editor

You May Also Like

Massachusetts Awarded Nearly $4 Million in Emergency Food and Shelter Assistance Under CARES Act

What To Know About Economic Impact Payment Debit Cards

Rep. Robinson Files Bill Requiring Hazard Pay For Essential Workers